QuID-Neuro: Quantum Bioanalytical Integration for Real-Time Diagnostics in Neuro-Oncology

As part of the Transfer Booster call for proposals for quantum technology demonstrators within QuantumBW, the project “QuID-Neuro: Quantum Bioanalytical Integration for Real-Time Diagnostics in Neuro-Oncology” was successfully awarded funding. Together with project partners the University of Stuttgart (PI3) and the University Medical Center Freiburg, the goal is to develop NV magnetometer quantum sensors for the detection of biomarkers in brain tumor medicine. NMR quantum sensor technology is expected to enable the high sensitivity and robust selectivity required within the highly complex cerebrospinal fluid. The scientific success of the entire clinical application depends on whether the sensor can reliably detect the critical D-2-hydroxyglutarate threshold despite interference from signals emitted by a multitude of molecular substances in the clinical samples. This requires, on the one hand, the development and integration of quantum sensor NMR with suitable microfluidics, combined with chemical pre-purification steps. The project duration is 1 year, and the IMS grant amount is 90 T€.